title: Tumour biomarkers: diagnostic, prognostic, and predictive.
authors.affiliation: University of Bristol Medical School, Bristol BS8 1TH, UK as0370@my.bristol.ac.uk.
authors.forename: Abigail
authors.initials: A
authors.lastname: Shaw
authors.affiliation: Institute of Clinical Neurosciences, Bristol.
authors.forename: Marcus D
authors.initials: MD
authors.lastname: Bradley
authors.affiliation: Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK.
authors.forename: Sean
authors.initials: S
authors.lastname: Elyan
authors.affiliation: Department of Neuropathology, Southmead Hospital, Bristol.
authors.forename: Kathreena M
authors.initials: KM
authors.lastname: Kurian
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D001932:Brain Neoplasms / Q000097:blood / Q000150:complications / Q000556:secondary*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D015820:Cadherins / Q000097:blood*; D047628:Estrogen Receptor alpha / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged; D004856:Postural Balance; D011237:Predictive Value of Tests; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000097:blood*; D011980:Receptors, Progesterone / Q000097:blood*; D013064:Speech Disorders / Q000209:etiology
chemical_list: D014408:Biomarkers, Tumor; D015820:Cadherins; D047628:Estrogen Receptor alpha; D018719:Erb-b2 Receptor Tyrosine Kinases; D011980:Receptors, Progesterone; C506487:ESR1 protein, human; C508053:ERBB2 protein, human